US Broker Ratings

ADMA Biologics Inc (ADMA) Stock Analysis: A Biotech with 63.74% Potential Upside and Strong Revenue Growth

Investors with an eye for opportunities in the biotechnology sector should take a closer look at ADMA Biologics Inc (ADMA). With an impressive revenue growth rate..

Vaxcyte, Inc. (PCVX) Stock Analysis: Exploring a 243% Potential Upside for Biotechnology Investors

Investors with a keen eye on the healthcare sector might want to take a closer look at Vaxcyte, Inc. (NASDAQ: PCVX), a burgeoning player in the..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Navigating a 72% Potential Upside Amid Market Challenges

Sarepta Therapeutics, Inc. (SRPT) stands as a prominent player in the biotechnology sector, focusing on the innovative development of RNA-targeted therapeutics and gene therapies, primarily for..

Oscar Health, Inc. (OSCR)

⚠️ No article content returned.

..

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: A Biotech Contender With 75% Upside Potential

Axsome Therapeutics, Inc. (NASDAQ: AXSM) is rapidly carving out a niche in the healthcare sector, specifically within the biotechnology industry. With a market capitalization of $4.96..

Viatris Inc. (VTRS) Stock Analysis: Exploring an 18.42% Potential Upside in the Healthcare Sector

Viatris Inc. (NASDAQ: VTRS) is generating a buzz in the healthcare sector, with a potential upside of 18.42% that has caught the attention of investors. As..

TransMedics Group, Inc. (TMDX) Stock Analysis: Poised for a 30% Upside with Innovative Organ Care Solutions

TransMedics Group, Inc. (NASDAQ: TMDX) has recently captured investor attention with its cutting-edge advancements in organ transplant technology and an enticing potential upside of 30.01%. As..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: Unpacking a 32% Upside Potential in the Biotech Sector

For investors seeking opportunities in the healthcare sector, Soleno Therapeutics, Inc. (NASDAQ: SLNO) presents an intriguing proposition. With a market capitalization of $4.56 billion, this biotechnology..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Exploring a 19% Potential Upside in the Medical Devices Sector

Bio-Rad Laboratories, Inc. (NYSE: BIO), a prominent player in the healthcare sector, particularly in the medical devices industry, presents an intriguing opportunity for investors seeking exposure..

AptarGroup, Inc. (ATR) Stock Analysis: Exploring a 9.84% Potential Upside Amid Steady Market Position

AptarGroup, Inc. (NYSE: ATR), a stalwart in the healthcare sector, specifically within the medical instruments and supplies industry, presents a compelling case for investors seeking stable..

Hologic, Inc. (HOLX) Stock Report: Analyzing Growth Potential Amidst Healthcare Innovation

Hologic, Inc. (HOLX), a prominent player in the healthcare sector focusing on medical instruments and supplies, stands out as a robust investment opportunity in the realm..

Cytokinetics, Incorporated (CYTK) Investor Outlook: Strong Analyst Buy Ratings and Nearly 95% Upside Potential

Cytokinetics, Incorporated (NASDAQ: CYTK) is capturing investor attention with its robust market position in the biotechnology sector, as analysts project a significant potential upside of nearly..

Solventum Corporation (SOLV): Investor Outlook Amid 13.77% Potential Upside

Solventum Corporation (NASDAQ: SOLV) stands out in the healthcare sector, particularly within the medical instruments and supplies industry. Based in the United States, this burgeoning company..

RadNet, Inc. (RDNT) Stock Analysis: A 24.67% Potential Upside in the Dynamic World of Diagnostics

RadNet, Inc. (NASDAQ: RDNT) stands out in the healthcare sector as a formidable player in diagnostics and research. With a market capitalization of $4.41 billion, RadNet..

BridgeBio Pharma, Inc. (BBIO) Investor Outlook: Analyzing the 32.83% Potential Upside Amidst a Robust Clinical Pipeline

BridgeBio Pharma, Inc. (BBIO), a commercial-stage biopharmaceutical company, is making waves in the healthcare sector with its innovative approach to treating genetic diseases and cancers. Based..

Integer Holdings Corporation (ITGR) Stock Analysis: A 29.83% Upside Potential in the Medical Devices Sector

Integer Holdings Corporation (NYSE: ITGR), a prominent player in the healthcare sector specializing in medical devices, presents a compelling case for investors with its robust growth..

Tempus AI, Inc. (TEM) Stock Analysis: Harnessing a Robust 75.4% Revenue Growth in Health Information Services

Tempus AI, Inc. (TEM), a healthcare technology leader, is making waves in the Health Information Services industry with its impressive revenue growth and strategic collaborations. Headquartered..

Bausch + Lomb Corporation (BLCO) Stock Report: Navigating a 1.01% Potential Upside Amidst Healthcare Growth

Bausch + Lomb Corporation (NYSE: BLCO), a globally renowned name in the eye health sector, presents a complex picture for investors seeking opportunities in the healthcare..

Molina Healthcare Inc (MOH) Stock Analysis: Exploring a 54.94% Potential Upside

Molina Healthcare Inc (NYSE: MOH), a key player in the healthcare sector, occupies a unique position in the market by focusing on providing managed healthcare services..

Madrigal Pharmaceuticals (MDGL) Stock Analysis: Navigating a Promising 42% Upside in the Biotech Sector

Madrigal Pharmaceuticals, Inc. (MDGL), a biotechnology firm based in West Conshohocken, Pennsylvania, is gaining attention in the healthcare sector for its pioneering approach to treating metabolic..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds